ArticleLeukemia research2015

The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.

M Lazenby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.